Canada Approves Its First Generic Version of Novo’s Ozempic
Canada has approved its first generic versions of Novo Nordisk A/S’s Ozempic, paving the way for cheaper access to the popular diabetes drugs.
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.